National and Kapodistrian University of Athens
Μελέτη της επίδρασης της ατορβαστατίνης στις ελαστικές ιδιότητες της αορτής σε ασθενείς με διαβήτη τύπου 2 με τη μέθοδο της τονομετρίας
Abstract
dc:descriptionType 2 diabetes is associated with a marked increase of cadiovascullar events. In recent years, great emphasis has been placed on the role of arterial stiffness in the development of cardiovascular diseases. Arterial stiffness, which is present as early as in impaired glucose metabolism, represents the link between diabetes and vascular events. Aortic pulse wave velocity (PWV), recorded by an applanation tonometer, is considered as an independent predictive factor of cardiovascular events.Aim of our study was to assess the effect of atorvastatin on the elastic properties of arteries in patients with type 2 diabetes and dyslipidemia.A total of 93 outpatients with type 2 diabetes who visited the Diabetes Center at the Laiko Hospital participated. The main inclusive criteria were: LDLc> 100 mg/dl, an adequate glycemic control (HbA1c 8.5 %), age 45-75 years, ankle-brachial pressure index >0.9 and absence of cardiovascular disease. Fifty subjects (17 men/33 women, mean age 60.78±8.19 years) were assigned to 10 mg atorvastatin daily and low-fat diet and 43 subjects (21 men/22 women, mean age 60.16±9.21 years) to low-fat diet only. Carotid-radial PWV (crPWV) and carotid-femoral PWV (cfPWV) were assessed using the SphygmoCor system (SphygmoCor AtCor Medical, Sidney, Australia). ΗbA1c, plasma lipids, hsCRp, fibrinogen, plasma osteoprotegerin (OPG) and metalloproteinase-9 (MMP-9) were assessed. The two groups were comparable regarding baseline clinical and laboratory characteristics, as well as baseline crPWV and cfPWV values. All patients were evaluated again at 3, 6 and 12 months, during which the same clinical examination, blood tests and PWV measurement were repeated.In the atorvastatin group, a significant reduction of crPWV was observed at 3 months of treatment by 3.50% (p<0.05), at 6 months by 3.39% (p<0.05) and at 12 months by 6.26%27(p=0.017). A significant decline of cfPWV was also observed at 3 months by 6.09% (p=0.001), at 6 months by 8.02% (p<0.001) and at 12 months by 6.39% (p<0.001). No significant improvement of PWV was achieved in the diet treated group. In the atorvastatin group, total cholesterol, LDLc and triglycerides were also significantly reduced (all p<0,05). No significant change of the rest clinical and biochemical parameters was observed in either group.The present prospective study showed, for the first time, the beneficial effect of atorvastatin on the elastic properties of both muscular and elastic arteries of patients with type 2 diabetes. This effect was obsereved as early as after 3 months therapy and it was maintained for at least 12 months.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Grigoropoulou, Pinelopi
- Γρηγοροπούλου, Πηνελόπη
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29594